FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135173402> ?p ?o ?g. }

• W2135173402 endingPage "R206" @default.
• W2135173402 startingPage "R206" @default.
• W2135173402 abstract "Inflammation associated with synovial expression of TNFα is a recognised feature of osteoarthritis (OA), although no studies have yet reported beneficial effects of anti-TNFα therapy on clinical manifestations of inflammation in OA. We conducted an open-label evaluation of adalimumab over 12 weeks in 20 patients with OA of the knee and evidence of effusion clinically. Inclusion criteria included daily knee pain for the month preceding study enrolment and a summed pain score of 125 to 400 mm visual analogue scale on the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) pain subscale. The primary outcome was the Osteoarthritis Research Society International/Outcome Measures in Rheumatology Clinical Trials (OARSI/OMERACT) response criterion at week 12. Secondary outcomes included the WOMAC pain score 20% and 50% improvement, WOMAC stiffness and function scores, patient and physician global visual analogue scale, as well as target joint swelling. Treatment was well tolerated and completed by 17 patients with withdrawals unrelated to lack of efficacy or adverse events. By intention to treat, an OARSI/OMERACT response was recorded in 14 (70%) patients. WOMAC pain 20% and 50% responses were recorded in 14 (70%) patients and eight (40%) patients, respectively. Significant improvement was observed in mean WOMAC pain, stiffness, function, physician and patient global, as well as target joint swelling at 12 weeks (P < 0.0001 for all). After treatment discontinuation, 16 patients were available for assessment at 22 weeks and OARSI/OMERACT response compared with baseline was still evident in 10 (50%) patients. Targeting TNFα may be of therapeutic benefit in OA and requires further evaluation in controlled trials. ClinicalTrials.gov: NCT00686439 ." @default.
• W2135173402 created "2016-06-24" @default.
• W2135173402 creator A5002965958 @default.
• W2135173402 creator A5019054146 @default.
• W2135173402 creator A5046007575 @default.
• W2135173402 creator A5069677255 @default.
• W2135173402 creator A5069979151 @default.
• W2135173402 creator A5071007504 @default.
• W2135173402 creator A5086248617 @default.
• W2135173402 date "2012-01-01" @default.
• W2135173402 modified "2023-10-06" @default.
• W2135173402 title "Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee" @default.
• W2135173402 cites W1997140718 @default.
• W2135173402 cites W1997957358 @default.
• W2135173402 cites W2002554431 @default.
• W2135173402 cites W2009524387 @default.
• W2135173402 cites W2017638669 @default.
• W2135173402 cites W2032306447 @default.
• W2135173402 cites W2032806251 @default.
• W2135173402 cites W2044953211 @default.
• W2135173402 cites W2053342448 @default.
• W2135173402 cites W2057647525 @default.
• W2135173402 cites W2058147305 @default.
• W2135173402 cites W2063152085 @default.
• W2135173402 cites W2086202612 @default.
• W2135173402 cites W2086920530 @default.
• W2135173402 cites W2094183877 @default.
• W2135173402 cites W2097250275 @default.
• W2135173402 cites W2130513475 @default.
• W2135173402 cites W2142107863 @default.
• W2135173402 cites W2142925530 @default.
• W2135173402 cites W2143772281 @default.
• W2135173402 cites W2146572310 @default.
• W2135173402 doi "https://doi.org/10.1186/ar4044" @default.
• W2135173402 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3580518" @default.
• W2135173402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23036475" @default.
• W2135173402 hasPublicationYear "2012" @default.
• W2135173402 type Work @default.
• W2135173402 sameAs 2135173402 @default.
• W2135173402 citedByCount "80" @default.
• W2135173402 countsByYear W21351734022013 @default.
• W2135173402 countsByYear W21351734022014 @default.
• W2135173402 countsByYear W21351734022015 @default.
• W2135173402 countsByYear W21351734022016 @default.
• W2135173402 countsByYear W21351734022017 @default.
• W2135173402 countsByYear W21351734022018 @default.
• W2135173402 countsByYear W21351734022019 @default.
• W2135173402 countsByYear W21351734022020 @default.
• W2135173402 countsByYear W21351734022021 @default.
• W2135173402 countsByYear W21351734022022 @default.
• W2135173402 countsByYear W21351734022023 @default.
• W2135173402 crossrefType "journal-article" @default.
• W2135173402 hasAuthorship W2135173402A5002965958 @default.
• W2135173402 hasAuthorship W2135173402A5019054146 @default.
• W2135173402 hasAuthorship W2135173402A5046007575 @default.
• W2135173402 hasAuthorship W2135173402A5069677255 @default.
• W2135173402 hasAuthorship W2135173402A5069979151 @default.
• W2135173402 hasAuthorship W2135173402A5071007504 @default.
• W2135173402 hasAuthorship W2135173402A5086248617 @default.
• W2135173402 hasBestOaLocation W21351734021 @default.
• W2135173402 hasConcept C126322002 @default.
• W2135173402 hasConcept C14184104 @default.
• W2135173402 hasConcept C142724271 @default.
• W2135173402 hasConcept C1862650 @default.
• W2135173402 hasConcept C197934379 @default.
• W2135173402 hasConcept C198451711 @default.
• W2135173402 hasConcept C204787440 @default.
• W2135173402 hasConcept C2776164576 @default.
• W2135173402 hasConcept C2777575956 @default.
• W2135173402 hasConcept C2778715236 @default.
• W2135173402 hasConcept C2779286237 @default.
• W2135173402 hasConcept C2780132546 @default.
• W2135173402 hasConcept C71924100 @default.
• W2135173402 hasConceptScore W2135173402C126322002 @default.
• W2135173402 hasConceptScore W2135173402C14184104 @default.
• W2135173402 hasConceptScore W2135173402C142724271 @default.
• W2135173402 hasConceptScore W2135173402C1862650 @default.
• W2135173402 hasConceptScore W2135173402C197934379 @default.
• W2135173402 hasConceptScore W2135173402C198451711 @default.
• W2135173402 hasConceptScore W2135173402C204787440 @default.
• W2135173402 hasConceptScore W2135173402C2776164576 @default.
• W2135173402 hasConceptScore W2135173402C2777575956 @default.
• W2135173402 hasConceptScore W2135173402C2778715236 @default.
• W2135173402 hasConceptScore W2135173402C2779286237 @default.
• W2135173402 hasConceptScore W2135173402C2780132546 @default.
• W2135173402 hasConceptScore W2135173402C71924100 @default.
• W2135173402 hasIssue "5" @default.
• W2135173402 hasLocation W21351734021 @default.
• W2135173402 hasLocation W21351734022 @default.
• W2135173402 hasLocation W21351734023 @default.
• W2135173402 hasLocation W21351734024 @default.
• W2135173402 hasOpenAccess W2135173402 @default.
• W2135173402 hasPrimaryLocation W21351734021 @default.
• W2135173402 hasRelatedWork W2116521994 @default.
• W2135173402 hasRelatedWork W2377248513 @default.
• W2135173402 hasRelatedWork W2412218867 @default.
• W2135173402 hasRelatedWork W2884879194 @default.
• W2135173402 hasRelatedWork W2949984626 @default.

• next